Annual EBITDA
-$8.40 M
+$6.34 M+43.02%
June 1, 2024
Summary
- As of February 10, 2025, KTRA annual EBITDA is -$8.40 million, with the most recent change of +$6.34 million (+43.02%) on June 1, 2024.
- During the last 3 years, KTRA annual EBITDA has risen by +$13.14 million (+61.02%).
Performance
KTRA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$2.37 M
-$291.00 K-14.01%
June 1, 2024
Summary
- As of February 10, 2025, KTRA quarterly EBITDA is -$2.37 million, with the most recent change of -$291.00 thousand (-14.01%) on June 1, 2024.
- Over the past year, KTRA quarterly EBITDA has dropped by -$1.36 million (-135.86%).
Performance
KTRA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$8.40 M
+$966.00 K+10.32%
June 1, 2024
Summary
- As of February 10, 2025, KTRA TTM EBITDA is -$8.40 million, with the most recent change of +$966.00 thousand (+10.32%) on June 1, 2024.
- Over the past year, KTRA TTM EBITDA has increased by +$2.18 million (+20.58%).
Performance
KTRA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KTRA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.0% | -135.9% | +20.6% |
| 3 y3 years | +61.0% | +60.2% | +65.9% |
| 5 y5 years | -0.2% | +60.2% | +65.9% |
KTRA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +169.4% | +135.9% | +148.3% | at high | +199.0% |
| 5 y | 5-year | +3.2% | +169.4% | +135.9% | +182.2% | +6.2% | +199.0% |
| alltime | all time | >+9999.0% | +169.4% | -134.8% | +212.6% | >+9999.0% | +199.0% |
Kintara Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | -$8.40 M(-43.0%) | -$2.37 M(+14.0%) | -$8.40 M(-10.3%) |
| Mar 2024 | - | -$2.08 M(+106.9%) | -$9.36 M(-11.4%) |
| Dec 2023 | - | -$1.00 M(-65.9%) | -$10.57 M(-19.0%) |
| Sep 2023 | - | -$2.95 M(-11.6%) | -$13.05 M(-11.4%) |
| Jun 2023 | -$14.74 M(-34.9%) | -$3.33 M(+1.4%) | -$14.74 M(-12.5%) |
| Mar 2023 | - | -$3.29 M(-5.7%) | -$16.84 M(-10.9%) |
| Dec 2022 | - | -$3.48 M(-24.8%) | -$18.90 M(-11.3%) |
| Sep 2022 | - | -$4.63 M(-14.9%) | -$21.30 M(-5.9%) |
| Jun 2022 | -$22.62 M(+5.0%) | -$5.44 M(+1.9%) | -$22.62 M(-5.2%) |
| Mar 2022 | - | -$5.34 M(-9.1%) | -$23.86 M(-5.0%) |
| Dec 2021 | - | -$5.88 M(-1.3%) | -$25.11 M(+2.0%) |
| Sep 2021 | - | -$5.96 M(-10.9%) | -$24.61 M(+14.2%) |
| Jun 2021 | -$21.54 M(+164.8%) | -$6.68 M(+1.4%) | -$21.54 M(+21.7%) |
| Mar 2021 | - | -$6.59 M(+22.6%) | -$17.70 M(+35.5%) |
| Dec 2020 | - | -$5.38 M(+86.1%) | -$13.06 M(+38.6%) |
| Sep 2020 | - | -$2.89 M(+1.8%) | -$9.42 M(+15.8%) |
| Jun 2020 | -$8.13 M(-3.0%) | -$2.84 M(+45.2%) | -$8.13 M(-0.7%) |
| Mar 2020 | - | -$1.96 M(+12.6%) | -$8.19 M(+3.6%) |
| Dec 2019 | - | -$1.74 M(+8.4%) | -$7.91 M(-1.0%) |
| Sep 2019 | - | -$1.60 M(-44.7%) | -$7.99 M(-4.7%) |
| Jun 2019 | -$8.38 M(-24.8%) | -$2.90 M(+73.6%) | -$8.38 M(+6.3%) |
| Mar 2019 | - | -$1.67 M(-8.2%) | -$7.89 M(-13.8%) |
| Dec 2018 | - | -$1.82 M(-9.0%) | -$9.15 M(-12.7%) |
| Sep 2018 | - | -$2.00 M(-16.7%) | -$10.48 M(-6.1%) |
| Jun 2018 | -$11.15 M(+34.3%) | -$2.40 M(-18.0%) | -$11.15 M(-3.4%) |
| Mar 2018 | - | -$2.93 M(-7.0%) | -$11.54 M(+11.0%) |
| Dec 2017 | - | -$3.15 M(+17.7%) | -$10.39 M(+16.3%) |
| Sep 2017 | - | -$2.67 M(-4.2%) | -$8.93 M(+7.6%) |
| Jun 2017 | -$8.30 M | -$2.79 M(+56.7%) | -$8.30 M(+10.0%) |
| Mar 2017 | - | -$1.78 M(+5.5%) | -$7.55 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | - | -$1.69 M(-17.5%) | -$7.18 M(+0.1%) |
| Sep 2016 | - | -$2.05 M(+0.7%) | -$7.17 M(+15.6%) |
| Jun 2016 | -$6.20 M(+42.8%) | -$2.03 M(+43.4%) | -$6.21 M(+38.7%) |
| Mar 2016 | - | -$1.42 M(-15.7%) | -$4.47 M(-4.9%) |
| Dec 2015 | - | -$1.68 M(+55.8%) | -$4.71 M(+14.7%) |
| Sep 2015 | - | -$1.08 M(+259.9%) | -$4.10 M(-5.6%) |
| Jun 2015 | -$4.35 M(+55.5%) | -$299.50 K(-81.8%) | -$4.35 M(+7.4%) |
| Mar 2015 | - | -$1.65 M(+53.1%) | -$4.05 M(-27.7%) |
| Dec 2014 | - | -$1.08 M(-18.4%) | -$5.59 M(+4.0%) |
| Sep 2014 | - | -$1.32 M(-58.7%) | -$5.38 M(+32.0%) |
| Jun 2014 | -$2.79 M(-66.3%) | - | - |
| Mar 2014 | - | -$3.20 M(+270.0%) | -$4.08 M(-50.8%) |
| Dec 2013 | -$8.28 M(>+9900.0%) | -$863.90 K(-112.7%) | -$8.28 M(+11.6%) |
| Sep 2013 | - | $6.80 M(-199.8%) | -$7.42 M(-47.8%) |
| Jun 2013 | - | -$6.81 M(-8.0%) | -$14.22 M(+91.9%) |
| Mar 2013 | - | -$7.40 M(>+9900.0%) | -$7.41 M(>+9900.0%) |
| Dec 2012 | - | -$3200.00(-23.8%) | -$11.50 K(-40.1%) |
| Sep 2012 | - | -$4200.00(+320.0%) | -$19.20 K(+1.6%) |
| Jun 2012 | - | -$1000.00(-67.7%) | -$18.90 K(-23.5%) |
| Jun 2012 | -$18.90 K(-42.9%) | - | - |
| Mar 2012 | - | -$3100.00(-71.6%) | -$24.70 K(-2.8%) |
| Dec 2011 | - | -$10.90 K(+179.5%) | -$25.40 K(-12.7%) |
| Sep 2011 | - | -$3900.00(-42.6%) | -$29.10 K(-12.1%) |
| Jun 2011 | -$33.10 K(+491.1%) | -$6800.00(+78.9%) | -$33.10 K(+22.1%) |
| Mar 2011 | - | -$3800.00(-74.0%) | -$27.10 K(+15.8%) |
| Dec 2010 | - | -$14.60 K(+84.8%) | -$23.40 K(+125.0%) |
| Sep 2010 | - | -$7900.00(+887.5%) | -$10.40 K(+316.0%) |
| Jun 2010 | -$5600.00 | -$800.00(+700.0%) | -$2500.00(+47.1%) |
| Mar 2010 | - | -$100.00(-93.8%) | -$1700.00(+6.3%) |
| Dec 2009 | - | -$1600.00 | -$1600.00 |
FAQ
- What is Kintara Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Kintara Therapeutics?
- What is Kintara Therapeutics annual EBITDA year-on-year change?
- What is Kintara Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly EBITDA year-on-year change?
- What is Kintara Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Kintara Therapeutics?
- What is Kintara Therapeutics TTM EBITDA year-on-year change?
What is Kintara Therapeutics annual EBITDA?
The current annual EBITDA of KTRA is -$8.40 M
What is the all time high annual EBITDA for Kintara Therapeutics?
Kintara Therapeutics all-time high annual EBITDA is -$5600.00
What is Kintara Therapeutics annual EBITDA year-on-year change?
Over the past year, KTRA annual EBITDA has changed by +$6.34 M (+43.02%)
What is Kintara Therapeutics quarterly EBITDA?
The current quarterly EBITDA of KTRA is -$2.37 M
What is the all time high quarterly EBITDA for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly EBITDA is $6.80 M
What is Kintara Therapeutics quarterly EBITDA year-on-year change?
Over the past year, KTRA quarterly EBITDA has changed by -$1.36 M (-135.86%)
What is Kintara Therapeutics TTM EBITDA?
The current TTM EBITDA of KTRA is -$8.40 M
What is the all time high TTM EBITDA for Kintara Therapeutics?
Kintara Therapeutics all-time high TTM EBITDA is -$1600.00
What is Kintara Therapeutics TTM EBITDA year-on-year change?
Over the past year, KTRA TTM EBITDA has changed by +$2.18 M (+20.58%)